Davey Scoon - Net Worth and Insider Trading

Davey Scoon Net Worth

The estimated net worth of Davey Scoon is at least $214,082 dollars as of 2024-11-08. Davey Scoon is the Director of Orthofix Medical Inc and owns about 10,917 shares of Orthofix Medical Inc (OFIX) stock worth over $214,082. Details can be seen in Davey Scoon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Davey Scoon has not made any transactions after 2015-05-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Davey Scoon

Davey Scoon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Davey Scoon owns 11 companies in total, including Albireo Pharma Inc (ALBO) , AMAG Pharmaceuticals Inc (AMAG) , and Virtus Artificial Intelligence & Technology Opportunities Fund (AIO) among others .

Click here to see the complete history of Davey Scoon’s form 4 insider trades.

Insider Ownership Summary of Davey Scoon

Ticker	Comapny	Transaction Date	Type of Owner
ALBO	Albireo Pharma Inc	2014-03-04	director
AMAG	AMAG Pharmaceuticals Inc	2020-06-02	director
AIO	Virtus Artificial Intelligence & Technology Opportunities Fund	2019-10-25	director
		2017-06-27	director
		2015-06-02	director
		2015-06-02	director
		2015-06-02	director
		2015-06-02	director
		2015-05-21	director
		2015-05-21	director
		2015-06-02	director

Davey Scoon Latest Holdings Summary

Davey Scoon currently owns a total of 1 stock. Davey Scoon owns 10,917 shares of Orthofix Medical Inc (OFIX) as of May 21, 2015, with a value of $214,082.

Latest Holdings of Davey Scoon

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
OFIX	Orthofix Medical Inc	2015-05-21	10,917	19.61	214,082

Holding Weightings of Davey Scoon

Davey Scoon Form 4 Trading Tracker

According to the SEC Form 4 filings, Davey Scoon has made a total of 0 transactions in Orthofix Medical Inc (OFIX) over the past 5 years. The most-recent trade in Orthofix Medical Inc is the sale of 5,709 shares on May 21, 2015, which brought Davey Scoon around $184,857.

Insider Trading History of Davey Scoon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Davey Scoon Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Davey Scoon Ownership Network

Ownership Network List of Davey Scoon

No Data

Ownership Network Relation of Davey Scoon

Davey Scoon Owned Company Details

What does Albireo Pharma Inc do?

Who are the key executives at Albireo Pharma Inc?

Davey Scoon is the director of Albireo Pharma Inc. Other key executives at Albireo Pharma Inc include director & President and CEO Cooper Ronald Harold Wilfred , Chief Human Resources Officer Michelle Graham , and CFO and Treasurer Harford Simon N.r. .

Albireo Pharma Inc (ALBO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Albireo Pharma Inc (ALBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Albireo Pharma Inc (ALBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Albireo Pharma Inc (ALBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Albireo Pharma Inc Insider Transactions

No Available Data

What does AMAG Pharmaceuticals Inc do?

Who are the key executives at AMAG Pharmaceuticals Inc?

Davey Scoon is the director of AMAG Pharmaceuticals Inc. Other key executives at AMAG Pharmaceuticals Inc include 10 percent owner Camber Capital Management Lp , Chief Operating Officer Anthony Casciano , and Interim CFO Brian Piekos .

AMAG Pharmaceuticals Inc (AMAG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc (AMAG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table.

AMAG Pharmaceuticals Inc Insider Transactions

No Available Data

What does Virtus Artificial Intelligence & Technology Opportunities Fund do?

Who are the key executives at Virtus Artificial Intelligence & Technology Opportunities Fund?

Davey Scoon is the director of Virtus Artificial Intelligence & Technology Opportunities Fund. Other key executives at Virtus Artificial Intelligence & Technology Opportunities Fund include other: Subadviser to the issuer Voya Investment Management Co , other: CIO-Subadviser to the issuer Paul Zemsky , and other: CIO-Subadviser to the issuer Vincent J Costa .

Virtus Artificial Intelligence & Technology Opportunities Fund (AIO) Insider Trades Summary

Over the past 18 months, Davey Scoon made no insider transaction in Virtus Artificial Intelligence & Technology Opportunities Fund (AIO). Other recent insider transactions involving Virtus Artificial Intelligence & Technology Opportunities Fund (AIO) include a net purchase of 2,925 shares made by Mcdaniel Connie D , and a net purchase of 832 shares made by Donald C Burke .

In summary, during the past 3 months, insiders sold 0 shares of Virtus Artificial Intelligence & Technology Opportunities Fund (AIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Virtus Artificial Intelligence & Technology Opportunities Fund (AIO) were sold and 3,757 shares were bought by its insiders, resulting in a net purchase of 3,757 shares.

Virtus Artificial Intelligence & Technology Opportunities Fund (AIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Virtus Artificial Intelligence & Technology Opportunities Fund Insider Transactions

No Available Data

What does Virtus Convertible & Income 2024 Target Term Fund do?

Who are the key executives at Virtus Convertible & Income 2024 Target Term Fund?

Davey Scoon is the director of Virtus Convertible & Income 2024 Target Term Fund. Other key executives at Virtus Convertible & Income 2024 Target Term Fund include other: Subadviser to the issuer Voya Investment Management Co , other: CIO-Subadviser to the issuer Paul Zemsky , and other: CIO-Subadviser to the issuer Vincent J Costa .

Virtus Convertible & Income 2024 Target Term Fund (CBH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Virtus Convertible & Income 2024 Target Term Fund (CBH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Virtus Convertible & Income 2024 Target Term Fund (CBH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Virtus Convertible & Income 2024 Target Term Fund (CBH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Virtus Convertible & Income 2024 Target Term Fund Insider Transactions

No Available Data

What does Virtus Convertible & Income Fund do?

Who are the key executives at Virtus Convertible & Income Fund?

Davey Scoon is the director of Virtus Convertible & Income Fund. Other key executives at Virtus Convertible & Income Fund include 10 percent owner Metlife Investment Management, Llc , other: Subadviser to the issuer Voya Investment Management Co , and other: CIO-Subadviser to the issuer Paul Zemsky .

Virtus Convertible & Income Fund (NCV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Virtus Convertible & Income Fund (NCV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Virtus Convertible & Income Fund (NCV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Virtus Convertible & Income Fund (NCV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Virtus Convertible & Income Fund Insider Transactions

No Available Data

What does Virtus Convertible & Income Fund II do?

Who are the key executives at Virtus Convertible & Income Fund II?

Davey Scoon is the director of Virtus Convertible & Income Fund II. Other key executives at Virtus Convertible & Income Fund II include 10 percent owner Metlife Investment Management, Llc , other: Subadviser to the issuer Voya Investment Management Co , and other: CIO-Subadviser to the issuer Paul Zemsky .

Virtus Convertible & Income Fund II (NCZ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Virtus Convertible & Income Fund II (NCZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Virtus Convertible & Income Fund II (NCZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Virtus Convertible & Income Fund II (NCZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Virtus Convertible & Income Fund II Insider Transactions

No Available Data

What does Virtus Dividend, Interest & Premium Strategy Fund do?

Who are the key executives at Virtus Dividend, Interest & Premium Strategy Fund?

Davey Scoon is the director of Virtus Dividend, Interest & Premium Strategy Fund. Other key executives at Virtus Dividend, Interest & Premium Strategy Fund include other: CEO - Subadviser to the issuer Christine Hurtsellers , other: CIO-Subadviser to the issuer Vincent J Costa , and other: CIO-Subadviser to the issuer Paul Zemsky .

Virtus Dividend, Interest & Premium Strategy Fund (NFJ) Insider Trades Summary

Over the past 18 months, Davey Scoon made no insider transaction in Virtus Dividend, Interest & Premium Strategy Fund (NFJ). Other recent insider transactions involving Virtus Dividend, Interest & Premium Strategy Fund (NFJ) include a net purchase of 1,244 shares made by Donald C Burke ,

In summary, during the past 3 months, insiders sold 0 shares of Virtus Dividend, Interest & Premium Strategy Fund (NFJ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Virtus Dividend, Interest & Premium Strategy Fund (NFJ) were sold and 1,244 shares were bought by its insiders, resulting in a net purchase of 1,244 shares.

Virtus Dividend, Interest & Premium Strategy Fund (NFJ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Virtus Dividend, Interest & Premium Strategy Fund Insider Transactions

No Available Data

What does Virtus AllianzGI Equity & Convertible Income Fund do?

Who are the key executives at Virtus AllianzGI Equity & Convertible Income Fund?

Davey Scoon is the director of Virtus AllianzGI Equity & Convertible Income Fund. Other key executives at Virtus AllianzGI Equity & Convertible Income Fund include other: Subadviser to the issuer Voya Investment Management Co , other: CIO-Subadviser to the issuer Paul Zemsky , and other: CIO-Subadviser to the issuer Vincent J Costa .

Virtus AllianzGI Equity & Convertible Income Fund (NIE) Insider Trades Summary

Over the past 18 months, Davey Scoon made no insider transaction in Virtus AllianzGI Equity & Convertible Income Fund (NIE). Other recent insider transactions involving Virtus AllianzGI Equity & Convertible Income Fund (NIE) include a net purchase of 720 shares made by Donald C Burke ,

In summary, during the past 3 months, insiders sold 0 shares of Virtus AllianzGI Equity & Convertible Income Fund (NIE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Virtus AllianzGI Equity & Convertible Income Fund (NIE) were sold and 720 shares were bought by its insiders, resulting in a net purchase of 720 shares.

Virtus AllianzGI Equity & Convertible Income Fund (NIE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Virtus AllianzGI Equity & Convertible Income Fund Insider Transactions

No Available Data

What does Orthofix Medical Inc do?

Who are the key executives at Orthofix Medical Inc?

Davey Scoon is the director of Orthofix Medical Inc. Other key executives at Orthofix Medical Inc include CECO & Interim CLO Puja Leekha , VP & Controller & Interim CFO Geoffrey C Gillespie , and President of Global Spine Kevin J. Kenny .

Orthofix Medical Inc (OFIX) Insider Trades Summary

Over the past 18 months, Davey Scoon made no insider transaction in Orthofix Medical Inc (OFIX). Other recent insider transactions involving Orthofix Medical Inc (OFIX) include a net sale of 8,243 shares made by Kevin J. Kenny , and a net purchase of 7,500 shares made by James F. Hinrichs .

In summary, during the past 3 months, insiders sold 0 shares of Orthofix Medical Inc (OFIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,243 shares of Orthofix Medical Inc (OFIX) were sold and 7,500 shares were bought by its insiders, resulting in a net sale of 743 shares.

Orthofix Medical Inc (OFIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Orthofix Medical Inc Insider Transactions

No Available Data

What does Virtus AllianzGI Diversified Income & Convertible Fund do?

Who are the key executives at Virtus AllianzGI Diversified Income & Convertible Fund?

Davey Scoon is the director of Virtus AllianzGI Diversified Income & Convertible Fund. Other key executives at Virtus AllianzGI Diversified Income & Convertible Fund include other: Subadviser to the issuer Voya Investment Management Co , other: CIO-Subadviser to the issuer Paul Zemsky , and other: CIO-Subadviser to the issuer Vincent J Costa .

Virtus AllianzGI Diversified Income & Convertible Fund (ACV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Virtus AllianzGI Diversified Income & Convertible Fund (ACV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Virtus AllianzGI Diversified Income & Convertible Fund (ACV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Virtus AllianzGI Diversified Income & Convertible Fund (ACV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Virtus AllianzGI Diversified Income & Convertible Fund Insider Transactions

No Available Data

What does Virtus Convertible & Income Fund do?

Who are the key executives at Virtus Convertible & Income Fund?

Virtus Convertible & Income Fund (NCVpA.PFD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Virtus Convertible & Income Fund (NCVpA.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Virtus Convertible & Income Fund (NCVpA.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Virtus Convertible & Income Fund (NCVpA.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Virtus Convertible & Income Fund Insider Transactions

No Available Data

Davey Scoon Mailing Address

Above is the net worth, insider trading, and ownership report for Davey Scoon. You might contact Davey Scoon via mailing address: C/o Amag Pharmaceuticals, Inc., 1100 Winter Street, Waltham Ma 02451.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.